Liver-assist device with a microfluidics-based vascular bed in an animal model

Annals of Surgery

Volumn 252, Issue 2, 2010, Pages 351-357

  Hsu, Wen Ming ^a,b   Carraro, Amedeo ^c   Kulig, Katherine M ^a   Miller, Mark L ^d   Kaazempur Mofrad, Mohammad ^e   Weinberg, Eli ^e   Entabi, Fateh ^f   Albadawi, Hassan ^f   Watkins, Michael T ^c,f   Borenstein, Jeffrey T ^g   Vacanti, Joseph P ^a,c   Neville, Craig ^a,c  

^a MASSACHUSETTS GENERAL HOSPITAL CANCER CENTER   (United States)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

^d HARVARD MEDICAL SCHOOL   (United States)

^e University of California at Berkeley   (United States)

^f MASSACHUSETTS GENERAL HOSPITAL   (United States)

^g CHARLES STARK DRAPER LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; DIMETICONE; POLYETHERSULFONE; SILASTIC;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIOVENOUS SHUNT; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; DEVICE; FEMORAL ARTERY; FEMORAL VEIN; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; LASER DOPPLER FLOWMETRY; LIVER; LIVER ASSIST DEVICE; LIVER CELL; LIVER FUNCTION; MEDICAL INSTRUMENTATION; MICROELECTROMECHANICAL SYSTEM; MICROFLUIDICS; NONHUMAN; NUDE RAT; PRIORITY JOURNAL; PROTEIN SECRETION; RAT; TREATMENT OUTCOME;

ANIMALS; ARTERIOVENOUS SHUNT, SURGICAL; BIOREACTORS; CELL CULTURE TECHNIQUES; CELL SURVIVAL; CELLS, CULTURED; DISEASE MODELS, ANIMAL; FEMUR; HEPATOCYTES; LASER-DOPPLER FLOWMETRY; LIVER, ARTIFICIAL; MALE; MICROCIRCULATION; MICROFLUIDICS; PROTEINS; RATS; RATS, INBRED LEW;

EID: 77955176059     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e3181e982ba     Document Type: Article

References (22)

1. UNOS. Annual Report of the U.S. Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients: Transplant Data 1994-2006. Rockville, MD: Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation; 2007.
2. Allen JW, Hassanein T, Bhatia SN. Advances in bioartificial liver devices. Hepatology. 2001;34:447-455.
3. Allen JW, Bhatia SN. Engineering liver therapies for the future. Tissue Eng. 2002;8:725-737.
4. Mazariegos GV, Kramer DJ, Lopez RC, et al. Safety observations in phase I clinical evaluation of the Excorp Medical Bioartificial Liver support system after the first four patients. ASAIO J. 2001;47:471-475.
5. Rozga J, Podesta L, LePage E, et al. A bioartificial liver to treat severe acute liver failure. Ann Surg. 1994;219:538-544; discussion 544-546.
6. Sussman NL, Gislason GT, Conlin CA, et al. The Hepatix extracorporeal liver assist device: initial clinical experience. Artif Organs. 1994;18:390-396.
7. Carraro A, Hsu WM, Kulig KM, et al. In vitro analysis of a hepatic device with intrinsic microvascular-based channels. Biomed Microdevices. 2008;10: 795-805.
8. Kaihara S, Kim S, Kim BS, et al. Survival and function of rat hepatocytes cocultured with nonparenchymal cells or sinusoidal endothelial cells on biodegradable polymers under flow conditions. J Pediatr Surg. 2000;35: 1287-1290.
9. Shin M, Matsuda K, Ishii O, et al. Endothelialized networks with a vascular geometry in microfabricated poly(dimethyl siloxane). Biomed Microdevices. 2004;6:269-278.
10. Fidkowski C, Kaazempur-Mofrad MR, Borenstein J, et al. Endothelialized microvasculature based on a biodegradable elastomer. Tissue Eng. 2005;11: 302-309.
11. Kaihara S, Kim SS, Kim BS, et al. Long-term follow-up of tissue-engineered intestine after anastomosis to native small bowel. Transplantation. 2000;69: 1927-1932.
12. Borenstein JT, Terai H, King KR, et al. Manufacturing technology for vascularized tissue engineering. Biomed Microdevices. 2002;4:167-175.
13. Seglen PO. Hepatocyte suspensions and cultures as tools in experimental carcinogenesis. J Toxicol Environ Health. 1979;5:551-560.
14. Kaihara S, Borenstein J, Koka R, et al. Silicon micromachining to tissue engineer branched vascular channels for liver fabrication. Tissue Eng. 2000; 6:105-117.
15. Cardon A, Chakfe N, Thaveau F, et al. Sealing of polyester prostheses with autologous fibrin glue and bone marrow. Ann Vasc Surg. 2000;14:543-552.
16. Park JK, Lee DH. Bioartificial liver systems: current status and future perspective. J Biosci Bioeng. 2005;99:311-319.
17. Shito M, Kim NH, Baskaran H, et al. In vitro and in vivo evaluation of albumin synthesis rate of porcine hepatocytes in a flat-plate bioreactor. Artif Organs. 2001;25:571-578.
18. Carvalho JS. Heterologous serum albumin as tracer for plasma volume measurements evaluated in conscious nondehydrated and 48-hour water-deprived rats. J Cardiovasc Pharmacol. 1989;13:603-607.
19. Yagi S, Iida T, Taniguchi K, et al. Impact of portal venous pressure on regeneration and graft damage after living-donor liver transplantation. Liver Transpl. 2005;11:68-75.
20. Tilles AW, Berthiaume F, Yarmush ML, et al. Bioengineering of liver assist devices. J Hepatobiliary Pancreat Surg. 2002;9:686-696.
21. Fee HJ, Levisman J, Doud RB, et al. High-output congestive failure from femoral arteriovenous shunts for vascular access. Ann Surg. 1976;183:321-323.
22. Tilles AW, Berthiaume F, Yarmush ML, et al. Critical issues in bioartificial liver development. Technol Health Care. 2002;10:177-186.